Trial Outcomes & Findings for Incidence of Postoperative Residual Neuromuscular Blockade in Portugal (NCT NCT03417804)
NCT ID: NCT03417804
Last Updated: 2021-07-06
Results Overview
Percentage of patients arriving PACU with a TOF ratio \< 0.9 measured as average of 3 consecutive TOF stimulations
COMPLETED
366 participants
No more than 10 minutes after operating room exit
2021-07-06
Participant Flow
Patients \> 18 years old submitted to surgery under general anesthesia with the use of non-depolarizing neuromuscular blocking agents from 10 public Portuguese hospitals
Participant milestones
| Measure |
Patients Proposed for Elective Surgical Procedures
A multicentre prospective observational study in adult patients undergoing different types of elective surgical procedures requiring general anaesthesia with non-depolarizing NMBAs was conducted between July 2018 and July 2019 at 10 public Portuguese hospitals
|
|---|---|
|
Overall Study
STARTED
|
366
|
|
Overall Study
COMPLETED
|
366
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Patients Proposed for Elective Surgical Procedures
n=366 Participants
A multicentre prospective observational study in adult patients undergoing different types of elective surgical procedures requiring general anaesthesia with non-depolarizing NMBAs was conducted between July 2018 and July 2019 at 10 public Portuguese hospitals
|
|---|---|
|
Age, Continuous
|
59 years
n=366 Participants
|
|
Sex: Female, Male
Female
|
207 Participants
n=366 Participants
|
|
Sex: Female, Male
Male
|
159 Participants
n=366 Participants
|
|
Region of Enrollment
Portugal
|
366 participants
n=366 Participants
|
PRIMARY outcome
Timeframe: No more than 10 minutes after operating room exitPercentage of patients arriving PACU with a TOF ratio \< 0.9 measured as average of 3 consecutive TOF stimulations
Outcome measures
| Measure |
Patients Proposed for Elective Surgical Procedures
n=366 Participants
A multicentre prospective observational study in adult patients undergoing different types of elective surgical procedures requiring general anaesthesia with non-depolarizing NMBAs was conducted between July 2018 and July 2019 at 10 public Portuguese hospitals
20 patients out of 366 presented with TOFr\< 0.9 which represents an incidence of 5,5%
|
|---|---|
|
Percentage of Patients With Postoperative Residual Neuromuscular Blockade
|
20 Participants
|
SECONDARY outcome
Timeframe: no more than 10 minutes after operating room exitPercentage of patients with severe postoperative residual neuromuscular blockade defined by a TOF ratio \< 0.7
Outcome measures
| Measure |
Patients Proposed for Elective Surgical Procedures
n=366 Participants
A multicentre prospective observational study in adult patients undergoing different types of elective surgical procedures requiring general anaesthesia with non-depolarizing NMBAs was conducted between July 2018 and July 2019 at 10 public Portuguese hospitals
20 patients out of 366 presented with TOFr\< 0.9 which represents an incidence of 5,5%
|
|---|---|
|
Percentage of Patients With Severe Residual Postoperative Neuromuscular Blockade
|
2 Participants
|
SECONDARY outcome
Timeframe: no more than 10 minutes after operating room exitAssociation of postoperative residual blockade and the use of reversal agents (neostigmine, sugammadex or none)
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: no more than 10 minutes after operating room exitTo evaluate the association of postoperative residual blockade and the use of intra-operative monitoring of neuromuscular blockade
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: no more than 10 minutes after operating room exitTo evaluate the association of postoperative residual blockade with co- morbidities and ASA status
Outcome measures
Outcome data not reported
Adverse Events
Patients Proposed for Elective Surgical Procedures
Serious adverse events
| Measure |
Patients Proposed for Elective Surgical Procedures
n=366 participants at risk
A multicentre prospective observational study in adult patients undergoing different types of elective surgical procedures requiring general anaesthesia with non-depolarizing NMBAs was conducted between July 2018 and July 2019 at 10 public Portuguese hospitals
|
|---|---|
|
Respiratory, thoracic and mediastinal disorders
Pulmunary thromboembolism
|
0.27%
1/366 • Number of events 1 • 1 day
Any untoward or unfavorable medical occurrence in a participant, including any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the participant's participation in the research, whether or not considered related to the participant's participation in the research
|
|
Musculoskeletal and connective tissue disorders
Severe residual neuromuscular blockade
|
0.27%
1/366 • Number of events 1 • 1 day
Any untoward or unfavorable medical occurrence in a participant, including any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the participant's participation in the research, whether or not considered related to the participant's participation in the research
|
Other adverse events
| Measure |
Patients Proposed for Elective Surgical Procedures
n=366 participants at risk
A multicentre prospective observational study in adult patients undergoing different types of elective surgical procedures requiring general anaesthesia with non-depolarizing NMBAs was conducted between July 2018 and July 2019 at 10 public Portuguese hospitals
|
|---|---|
|
Respiratory, thoracic and mediastinal disorders
Hypoxemia
|
2.5%
9/366 • Number of events 9 • 1 day
Any untoward or unfavorable medical occurrence in a participant, including any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the participant's participation in the research, whether or not considered related to the participant's participation in the research
|
|
General disorders
Sore throat
|
0.27%
1/366 • Number of events 1 • 1 day
Any untoward or unfavorable medical occurrence in a participant, including any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the participant's participation in the research, whether or not considered related to the participant's participation in the research
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place